The race for antimicrobials in the multidrug resistance era.

about

Current Screening Methodologies in Drug Discovery for Selected Human Diseases

P2860

Q57169512-2E7611A1-91E2-40C1-968B-27507393463C

P2860

The race for antimicrobials in the multidrug resistance era.

Item

http://www.wikidata.org/entity/Q50071895

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

The race for antimicrobials in the multidrug resistance era.

@en

The race for antimicrobials in the multidrug resistance era.

@nl

type

Item

label

The race for antimicrobials in the multidrug resistance era.

@en

The race for antimicrobials in the multidrug resistance era.

@nl

prefLabel

The race for antimicrobials in the multidrug resistance era.

@en

The race for antimicrobials in the multidrug resistance era.

@nl

P1476

The race for antimicrobials in the multidrug resistance era.

@en

P2093

Diego Romero

http://www.w3.org/2001/XMLSchema#string

P2860

A new antibiotic kills pathogens without detectable resistance

Use of ichip for high-throughput in situ cultivation of "uncultivable" microbial species

Antibacterial Nucleoside-Analog Inhibitor of Bacterial RNA Polymerase

Total synthesis of [Ψ[C(═NH)NH]Tpg(4)]vancomycin and its (4-chlorobiphenyl)methyl derivative: impact of peripheral modifications on vancomycin analogues redesigned for dual D-Ala-D-Ala and D-Ala-D-Lac binding.

Vancomycin revisited - 60 years later

Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms.

Total syntheses and initial evaluation of [Ψ[C(═S)NH]Tpg⁴]vancomycin, [Ψ[C(═NH)NH]Tpg⁴]vancomycin, [Ψ[CH₂NH]Tpg⁴]vancomycin, and their (4-chlorobiphenyl)methyl derivatives: synergistic binding pocket and peripheral modifications for the glycopeptide

Total synthesis of [Ψ[C(═S)NH]Tpg4]vancomycin aglycon, [Ψ[C(═NH)NH]Tpg4]vancomycin aglycon, and related key compounds: reengineering vancomycin for dual D-Ala-D-Ala and D-Ala-D-Lac binding.

Total synthesis and evaluation of [Psi[CH2NH]Tpg4]vancomycin aglycon: reengineering vancomycin for dual D-Ala-D-Ala and D-Ala-D-Lac binding.

Antibacterial drug discovery in the resistance era.

P304

976-978

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/1751-7915.12884

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Antonio de Vicente

Carlos Molina-Santiago

P577

2017-12-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29205906

http://www.w3.org/2001/XMLSchema#string

P921

multiple drug resistance

P932

6196379

http://www.w3.org/2001/XMLSchema#string

The race for antimicrobials in the multidrug resistance era.

about

P2860

P2860

The race for antimicrobials in the multidrug resistance era.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932